Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat® improves outcomes vs mono-components in COPD in two 1-year studies[removed]Roland Buhl - Respimat - Document - PDFSEARCH.IO

First Page	Meta Content
	Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat® improves outcomes vs mono-components in COPD in two 1-year studies[removed]Roland Buhl Add to Reading List Document Date: 2014-09-07 02:29:07 Open Document File Size: 408,50 KB Share Result on Facebook City Mainz / / Company TDI / AEs / R A N D O M I S A T / / Country Germany / / Facility Mainz University Hospital / / MedicalCondition cardiac arrhythmia / myocardial infarction / Pulmonary / heart failure / COPD / pharmacological COPD / Paroxysmal tachycardia / very severe COPD / asthma / / Organization Mainz University Hospital / Roland Buhl Pulmonary Department / / Person Rob Kite / / / Product Rescue medication / / SocialTag Pulmonary function testing Respiratory physiology Muscarinic antagonists Thiophenes Tiotropium bromide Spirometry Chronic obstructive pulmonary disease Bronchodilator Pulmonology Medicine

Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat® improves outcomes vs mono-components in COPD in two 1-year studies[removed]Roland BuhlAdd to Reading List